Type 2 Diabetes Stem Cell Therapy

Type 2 diabetes is a serious condition that can lead to a number of health complications, including heart disease, stroke, and kidney disease. One of the most promising treatments for type 2 diabetes is stem cell therapy. Stem cells are a type of cell that can develop into other types of cells. They have the ability to repair and regenerate tissue. This makes them a potential treatment for a number of conditions, including type 2 diabetes. There are two main types of stem cells: embryonic stem cells and adult stem cells. Embryonic stem cells are derived from embryos and have the ability to develop into any type of cell in the body. Adult stem cells are found in adults and can develop into a limited number of cell types. The first clinical trial of stem cell therapy for type 2 diabetes was conducted in 2014. The trial involved injecting stem cells into the pancreas of people with type 2 diabetes. The stem cells were derived from the patient’s own bone marrow. The trial found that the stem cell treatment was safe and improved the function of the pancreas. The stem cells appeared to help the pancreas produce more insulin, which is the hormone that helps regulate blood sugar levels. A larger clinical trial is currently underway to confirm the findings of the first trial. If the results of the second trial are positive, stem cell therapy could become a standard treatment for type 2 diabetes. There are a number of other potential applications of stem cell therapy. For example, stem cells could be used to treat other conditions that are caused by damage to the pancreas, such as pancreatitis. Stem cell therapy is a promising new treatment for type 2 diabetes. However, more research is needed to confirm the findings of the clinical trials and to determine the long-term safety and efficacy of the treatment.

 "Type 2 Diabetes Stem Cell Therapy." https://trustemcell.com/type-2-diabetes-stem-cell-therapy/. Accessed 24 Oct. 2022.

 "Efficacy of Stem Cell Application in Diabetes Mellitus - NCBI." 26 Feb. 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007200/. Accessed 24 Oct. 2022.

 "Bone marrow-derived stem cell therapy for type 2 diabetes mellitus." 6 Dec. 2016, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182211/. Accessed 24 Oct. 2022.

The information below is the recommended stem cell therapy protocol for this condition 

Route of AdministrationDoseTime (Days)Total Cells
IV100,000,0004400,000,000
Myers cocktail/NAD1N/A
Total400,000,000